How much does entrectinib cost in India?

Entrectinib (Entrectinib) is a tyrosine kinase inhibitor with central nervous system activity and is widely used in the treatment of tumor diseases. It can cross the blood-brain barrier and has a good therapeutic effect on brain metastases. As an anti-cancer targeted drug, entrectinib is mainly used to inhibit the growth and spread of tumors. Regarding the Indian version of entrectinib, there is currently no definite information indicating that generic versions of entrectinib are produced or sold in India. However, it is understood that entrectinib has received marketing approval in many regions around the world, and has been verified by multiple clinical trials and experience, and its efficacy and safety have been fully affirmed.

Enrectinib is an effective anti-cancer targeted drug that has good efficacy in the treatment ofROS1-positive locally advanced or metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumors. During use, it is necessary to pay close attention to the patient's symptoms and reactions, and adjust the dosage and frequency of medication according to the specific situation. Entrectinib may cause some adverse reactions during treatment, such as cognitive impairment, mood disorders, dizziness, sleep disorders and other central nervous system effects. In addition, there is a risk of hepatotoxicity, so when receiving treatment, patients need to be closely observed for symptoms and reactions, and the dosage and frequency of medication need to be adjusted according to the specific situation.

There are currently generic versions of entrectinib on the market. The ingredients of these drugs are very close to the original drugs. They are produced by Laos Lucius Pharmaceuticals, ASEAN Pharmaceuticals, Second Pharmaceuticals and other pharmaceutical factories. The price per box is between 1-6 thousand yuan. Of course, this price will also be affected by international exchange rates and fluctuate.